We have investigated 8 cases of clinically manifest hepatitis type B said to be
posttransfusion hepatitis that have become known in the years 1978-1981. Paired samples of
serum from all 54 blood donors implicated have been drawn at the time of the donation in
question as well as a few months later. Only 1 donor, negative for HBsAg but positive with
high titer for anti-HBc, could have been a possible source of infection. There is strong
evidence that this person is a chronic low level carrier. In the case of 2 other patients
transmission of hepatitis by clotting factors from pooled plasma cannot be denied. Regarding
the remaining 5 cases, there is no hint whatsoever for a causal connection between blood
transfusion and hapatitis type B.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.